This article is a correction to:
Editorial: Reviews in rheumatology
Yves Henrotin
Zoltan Szekanecz
Kayo Masuko- 1musculoSKeletal Innovative Research Lab (mSKIL), University of Liège, Liège, Belgium
- 2Artialis SA, Liège, Belgium
- 3Princess Paola Hospital, Department of Physical Therapy and Rehabilitation, Vivalia, Marche-en-Famenne, Belgium
- 4The Osteoarthritis Foundation, Boncelles, Belgium
- 5Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 6Akasaka Sanno Medical Center, Tokyo, Japan
A corrigendum on
Editorial: Reviews in rheumatology
by Henrotin, Y., Szekanecz, Z., and Masuko, K. (2023). Front. Med. 10:1153419. doi: 10.3389/fmed.2023.1153419
In the published article, there was an error in affiliations 4, 5 and 6.
Instead of “5Akasaka Sanno Medical Center, Tokyo, Japan, 6Rheumatology Department, University of Debrecen, Debrecen, Hungary.”
It should be “5Department of Rheumatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 6Akasaka Sanno Medical Center, Tokyo, Japan.”
And, Instead of “Szekanecz4,5, Masuko5,6,” it should be “Szekanecz5, Masuko6.”
In the published article, there was an error in the Conflict of Interest statement. “YH and ZS were employed by the Osteoarthritis Foundation.” The correct Conflict of Interest statement appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Conflict of interest
YH was employed by the Osteoarthritis Foundation. YH is the founder and executive president of Artialis SA. He has also received consulting fees from Grunenthal, Tilman, Expanscience, Genequine, Allegro, Thuasne, Nestlé, and Ibsa.
The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: rheumatoid arthritis, systemic lupus erythematosus (SLE), frozen shoulder, cytokines, biomarkers, mitochondria
Citation: Henrotin Y, Szekanecz Z and Masuko K (2023) Corrigendum: Editorial: Reviews in rheumatology. Front. Med. 10:1187603. doi: 10.3389/fmed.2023.1187603
Received: 16 March 2023; Accepted: 17 March 2023;
Published: 29 March 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Henrotin, Szekanecz and Masuko. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yves Henrotin, eWhlbnJvdGluJiN4MDAwNDA7dWxpZWdlLmJl